| Theresa Fink, CRNFA | |
|
1 Capital Way, Pennington, NJ 08534-2520 | |
| (609) 303-4000 | |
| Not Available |
| Full Name | Theresa Fink |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Registered Nurse First Assistant |
| Location | 1 Capital Way, Pennington, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013423334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WR0006X | Registered Nurse - Registered Nurse First Assistant | 26NO09893700 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Theresa Fink, CRNFA 1 Capital Way, Pennington, NJ 08534-2520 Ph: () - | Theresa Fink, CRNFA 1 Capital Way, Pennington, NJ 08534-2520 Ph: (609) 303-4000 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today jointly announced that Seattle Genetics and Millennium have entered into an agreement to globally develop and commercialize brentuximab vedotin (SGN-35).
Over the past ten years, Computed Tomography (CT) vendors have been in a fierce race to capitalise on the trend for multi-slice CT equipment. However, in the last three years, increasing concerns over radiation exposure from CT examinations have driven a focus on dose-reduction, and CT product development has followed suit. As battle lines are drawn in the dose-reduction arena, InMedica (www.in-medica.com) analyses the competition for CT slices in its new report "The World Market for CT and PET-CT Equipment." Importantly, what will this mean for dose-reduction?
Phylogica Ltd, a leading Australian peptide drug discovery company, and Pepscan Therapeutics, a Dutch biopharmaceutical firm focusing on protein mimicry technology, today announce that they have entered a Research Collaboration and Option Agreement to evaluate the combination of their complementary peptide technologies for drug discovery.
Mobile Stroke Units, vehicles equipped to provide stroke treatment before reaching a hospital, provided lifesaving care to stroke patients in Manhattan approximately 30 minutes faster, compared to patients transported to hospitals in traditional ambulances and who did not receive stroke treatment until arriving at the hospital, according to new research published in the Journal of the American Heart Association, the open access journal of the American Heart Association.
› Verified 5 days ago
Theresa Marie Archer, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 108 Straube Center Blvd Suite I-17, Pennington, NJ 08534 Phone: 609-751-6625 | |
Samantha Offenback, Registered Nurse Medicare: Medicare Enrolled Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 800-637-2374 | |
Susan Scully, RNFA, MSN, CNOR Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-537-6377 | |
Deeca Joyceann Dunham, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 | |
Marlene Gillio, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 25b West Delaware Ave, Pennington, NJ 08534 Phone: 215-915-6517 | |
Taryn Whitehead, APN Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way Ste 356, Pennington, NJ 08534 Phone: 609-537-6000 Fax: 609-537-6002 |